POMPANO BEACH, Fla., January 13, 2025 – PRISM MediaWire – BioStem Technologies, Inc. (OTC: BSEM) (“BioStem”, “we”, “us”, or “our”), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announced selected preliminary financial results for the fiscal fourth quarter and full year ended December 31, 2024. 2024 Preliminary … Continue reading “BioStem Technologies Announces Record Preliminary Fourth Quarter Net Revenue of $102.9 Million, with Full-Year 2024 Net Revenue Expected to Reach $301.8 Million”
Breaking News
Breaking News
Quantum Computing Era is Here and Growing: The Dawn of Practical Artificial Intelligence (AI) and Cybersecurity Applications
Hauppauge, NY, January 8, 2025 – PRISM MediaWire – AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW),…
January 8, 2025
Breaking News
UAV Corp. (UMAV) Further Reduces Authorized Shares to 500 Million
Company Secures $20 Million Funding Commitment to Advance Aerospace & Defense Initiatives WEWAHITCHKA-PORT ST JOE,…
January 8, 2025
Breaking News
Klotho Neurosciences to Present at Biotech Showcase 2025 during J.P. Morgan Healthcare Week in San Francisco
Company to present at 3:00 p.m. PT on Tuesday, January 14, at the Hilton San…
January 8, 2025
Breaking News
Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer
Dr. Billings is a renowned diagnostics specialist with a history of commercializing novel assays in…
January 8, 2025
Breaking News
SMC Entertainment Closes Acquisition of Boutique Investment Manager, Bateau Asset Management, Providing Entry to Australian and Southeast Asian Financial Services Markets
Bateau Asset Management brings to SMC Entertainment: Foundational acquisition into International Financial Services Sector Well-established…
January 8, 2025
Breaking News
BioStem Technologies Launches Clinical Trial to Demonstrate the Therapeutic Benefits of its BioREtain® Technology in Treating Diabetic Foot Ulcers Using Vendaje®
Study of Vendaje® versus standard of care aims to show superior wound treatment, supporting market…
January 8, 2025
Breaking News
PRISM MarketView Spotlights Quoin Pharmaceuticals CEO Dr. Michael Myers as Specialty Pharma Shares News of Highly Positive Interim Data in Most Advanced, Comprehensive Netherton Syndrome Trials
Published Before-and-After Photos Highlight Dramatic Improvements in Netherton Syndrome Patient Treated with QRX003 New York,…
January 7, 2025
Breaking News
EzFill Holdings, Inc. Successfully Closes Acquisition of Shell Fleet, Accelerating Nationwide Mobile Fueling Expansion
Following the Closing of its 2024 Transactions, EzFill is Now Operating in Miami, West Palm…
January 7, 2025
Breaking News
Formation Minerals, Inc. Announces Entry Into $10,000,000 Equity Financing Agreement with GHS Investments, LLC
Jacksboro, TX, January 7, 2025 – PRISM MediaWire – Formation Minerals, Inc. (”Formation” or the…
January 7, 2025
Breaking News
Oncocyte Expands Market Opportunity for VitaGraft™ Kidney
Medicare coverage expanded following study showing that monitoring with Oncocyte’s assay significantly reduces time to…
January 6, 2025
Breaking News
Blaqclouds Provides Update on the Successful Soft Launch of ShopwithCrypto.io
Revolutionizing Crypto Spendability with Real-Time Gift Card Purchases ROBESONIA, Pa., Jan. 06, 2025 – PRISM MediaWire…
January 6, 2025
Breaking News
UAV Corp (UMAV) Working on Securing $1.5 Billion in Contracts and Announces Groundbreaking Partnership with Atlantic Industrial Group
CEO Letter Published on OTCMarkets.com WEWAHITCHKA-PORT ST JOE, Fla., Jan. 06, 2025 – PRISM MediaWire…
January 6, 2025
Breaking News
AmpliTech Group Announces Receipt of Notice of Allowance for Another Patent For Its LNA Technology
Hauppauge, NY, January 6, 2025 – PRISM MediaWire – AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW),…
January 6, 2025